Source: https://www.bankofengland.co.uk/-/media/boe/files/prudential-regulation/policy-statement/2026/january/ps126app1.pdf · captured 2026-09-29 · checked 2026-09-29 · c75b8196

Page 273 thumbnail
14399 This document is effective from 1 January 2027 to accompany PS1/26.
14400Please see: www.bankofengland.co.uk/prudential-regulation/publication/2026/january/implementation-of-basel-3-1-final-rules-policy-statement.
14401 PRA2026/1
14403 (c) by way of derogation, where an institution additionally calculates a stress scenario risk
14404 measure referred to in Article 325bk for one or more non-modellable risk factors that relate
14405 to that data input, the institution may also include the changes in those non-modellable risk
14406 factors for the purposes of determining the theoretical changes in portfolio value for the
14407 P&L attribution requirements in accordance with Article 325bg.
14409 Systematic and idiosyncratic market risk
14410 5. An institution shall ensure the data inputs used for their risk measurement model are
14411 appropriate for adequately capturing both systematic and idiosyncratic market risk.
14412 Where the data inputs in paragraph 11 do not allow for adequate capture of systematic or
14413 idiosyncratic market risks, the institution shall ensure that the systematic or idiosyncratic market
14414 risk is capitalised separately through non-modellable risk factors in accordance with the
14415 methodology set out in Article 325bk.
14416 Reflection of volatility and correlation
14417 6. An institution shall ensure that:
14418 (a) the data inputs used in their risk measurement model accurately reflect the volatilities of
14419 and correlations between risk factors that are included in the risk measurement model; and
14421 (b) any transformations applied to data inputs shall not have the effect of reducing the
14422 accuracy of the volatility of and correlations between risk factors that are included in the
14423 risk measurement model.
14425 Consistency of data inputs with verifiable prices and with front-office and back-office prices
14426 7. An institution shall perform at least quarterly analysis to compare prices series in point (a) with
14427 the alternative price series in points (b), (c) and (d) as follows:
14428 (a) the price series used in the risk measurement model;
14430 (b) price data used to generate the actual changes in the value of the portfolio and the
14431 hypothetical changes in the value of the portfolio;
14433 (c) verifiable prices in accordance with Article 325be; and
14435 (d) price data used in the independent price verification process in accordance with paragraph
14436 8 of Trading Book (CRR) Part Article 105 including daily and intra-month data where this is
14437 collected.
14439 8. For the purpose of performing the analysis in paragraph 7, the institution:
14440 (a) shall compare the levels, volatilities and correlations of price series from these four
14441 alternative price series for the purpose of highlighting differences between the sources that
14442 are material in terms of their impact on the measurement of the expected shortfall;
14444 (b) shall, where the four alternative price series are derived from overlapping underlying data,
14445 explicitly reflect this in the analysis. The institution shall give due considerations to price
14446 uncertainty; and
14448 (c) shall combine all available information, including information about intra-day movements,
14449 to derive a statistical test or tests that monitor price series referred to in this paragraph to
14450 assess whether the price data used in the risk measurement model results in an
14451 understatement of the measurement of the expected shortfall,
14453 Page 273 of 492